
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma
Britt Lauenborg, Louise Dahl Christensen, Ulrik Ralfkiær, et al.
Oncotarget (2015) Vol. 6, Iss. 17, pp. 15235-15249
Open Access | Times Cited: 30
Britt Lauenborg, Louise Dahl Christensen, Ulrik Ralfkiær, et al.
Oncotarget (2015) Vol. 6, Iss. 17, pp. 15235-15249
Open Access | Times Cited: 30
Showing 1-25 of 30 citing articles:
Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells
Michael Boice, Darin Salloum, Frédéric Mourcin, et al.
Cell (2016) Vol. 167, Iss. 2, pp. 405-418.e13
Open Access | Times Cited: 228
Michael Boice, Darin Salloum, Frédéric Mourcin, et al.
Cell (2016) Vol. 167, Iss. 2, pp. 405-418.e13
Open Access | Times Cited: 228
Malignant inflammation in cutaneous T‐cell lymphoma—a hostile takeover
Thorbjørn Krejsgaard, Lise M. Lindahl, Nigel P. Mongan, et al.
Seminars in Immunopathology (2016) Vol. 39, Iss. 3, pp. 269-282
Open Access | Times Cited: 129
Thorbjørn Krejsgaard, Lise M. Lindahl, Nigel P. Mongan, et al.
Seminars in Immunopathology (2016) Vol. 39, Iss. 3, pp. 269-282
Open Access | Times Cited: 129
TNF Receptor 2 Makes Tumor Necrosis Factor a Friend of Tumors
Yuqiao Sheng, Feng Li, Zhihai Qin
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 101
Yuqiao Sheng, Feng Li, Zhihai Qin
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 101
An overview of cutaneous T cell lymphomas
Nooshin Bagherani, Bruce R. Smoller
F1000Research (2016) Vol. 5, pp. 1882-1882
Open Access | Times Cited: 97
Nooshin Bagherani, Bruce R. Smoller
F1000Research (2016) Vol. 5, pp. 1882-1882
Open Access | Times Cited: 97
STAT5 induces miR-21 expression in cutaneous T cell lymphoma
Lise M. Lindahl, Simon Fredholm, Claudine Joseph, et al.
Oncotarget (2016) Vol. 7, Iss. 29, pp. 45730-45744
Open Access | Times Cited: 49
Lise M. Lindahl, Simon Fredholm, Claudine Joseph, et al.
Oncotarget (2016) Vol. 7, Iss. 29, pp. 45730-45744
Open Access | Times Cited: 49
HVEM network signaling in cancer
John R. Šedý, Parham Ramezani-Rad
Advances in cancer research (2019), pp. 145-186
Closed Access | Times Cited: 43
John R. Šedý, Parham Ramezani-Rad
Advances in cancer research (2019), pp. 145-186
Closed Access | Times Cited: 43
Cellular Interactions and Inflammation in the Pathogenesis of Cutaneous T-Cell Lymphoma
Veronica Stolearenco, Martin R. J. Namini, Siri S. Hasselager, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 39
Veronica Stolearenco, Martin R. J. Namini, Siri S. Hasselager, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 39
The Roles of TNFR2 Signaling in Cancer Cells and the Tumor Microenvironment and the Potency of TNFR2 Targeted Therapy
Hiroyuki Takahashi, Gumpei Yoshimatsu, Denise L. Faustman
Cells (2022) Vol. 11, Iss. 12, pp. 1952-1952
Open Access | Times Cited: 24
Hiroyuki Takahashi, Gumpei Yoshimatsu, Denise L. Faustman
Cells (2022) Vol. 11, Iss. 12, pp. 1952-1952
Open Access | Times Cited: 24
Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma: results from a phase I/II open-label multicenter study
Swaminathan P. Iyer, Auris Huen, Weiyun Z. Ai, et al.
Haematologica (2023)
Open Access | Times Cited: 13
Swaminathan P. Iyer, Auris Huen, Weiyun Z. Ai, et al.
Haematologica (2023)
Open Access | Times Cited: 13
Unveiling the Role of the Cellular Tumor Microenvironment and the Therapeutic Targets it Provides in Cutaneous T-Cell Lymphoma
Nikolaos A. Chinas, Stella Kaliampou, Vasiliki Nikolaou
Current Oncology Reports (2025)
Open Access
Nikolaos A. Chinas, Stella Kaliampou, Vasiliki Nikolaou
Current Oncology Reports (2025)
Open Access
SATB1 in Malignant T Cells
Simon Fredholm, Andreas Willerslev-Olsen, Özcan Met, et al.
Journal of Investigative Dermatology (2018) Vol. 138, Iss. 8, pp. 1805-1815
Open Access | Times Cited: 45
Simon Fredholm, Andreas Willerslev-Olsen, Özcan Met, et al.
Journal of Investigative Dermatology (2018) Vol. 138, Iss. 8, pp. 1805-1815
Open Access | Times Cited: 45
High activation of STAT5A drives peripheral T-cell lymphoma and leukemia
Barbara Maurer, Harini Nivarthi, Bettina Wingelhofer, et al.
Haematologica (2019) Vol. 105, Iss. 2, pp. 435-447
Open Access | Times Cited: 40
Barbara Maurer, Harini Nivarthi, Bettina Wingelhofer, et al.
Haematologica (2019) Vol. 105, Iss. 2, pp. 435-447
Open Access | Times Cited: 40
Lymphotoxin‐α promotes tumor angiogenesis in HNSCC by modulating glycolysis in a PFKFB3‐dependent manner
Jiegang Yang, Wei‐Ming Wang, Hou‐Fu Xia, et al.
International Journal of Cancer (2019) Vol. 145, Iss. 5, pp. 1358-1370
Open Access | Times Cited: 32
Jiegang Yang, Wei‐Ming Wang, Hou‐Fu Xia, et al.
International Journal of Cancer (2019) Vol. 145, Iss. 5, pp. 1358-1370
Open Access | Times Cited: 32
Molecular and Genomic Landscape of Peripheral T-Cell Lymphoma
Javeed Iqbal, Catalina Amador, Timothy W. McKeithan, et al.
Cancer treatment and research (2018), pp. 31-68
Closed Access | Times Cited: 31
Javeed Iqbal, Catalina Amador, Timothy W. McKeithan, et al.
Cancer treatment and research (2018), pp. 31-68
Closed Access | Times Cited: 31
The Microenvironment’s Role in Mycosis Fungoides and Sézary Syndrome: From Progression to Therapeutic Implications
Alessandro Pileri, Alba Guglielmo, Vieri Grandi, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2780-2780
Open Access | Times Cited: 23
Alessandro Pileri, Alba Guglielmo, Vieri Grandi, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2780-2780
Open Access | Times Cited: 23
Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas
Anna Orlova, Bettina Wingelhofer, Heidi A. Neubauer, et al.
Expert Opinion on Therapeutic Targets (2017) Vol. 22, Iss. 1, pp. 45-57
Open Access | Times Cited: 22
Anna Orlova, Bettina Wingelhofer, Heidi A. Neubauer, et al.
Expert Opinion on Therapeutic Targets (2017) Vol. 22, Iss. 1, pp. 45-57
Open Access | Times Cited: 22
BCL11B-Mediated Epigenetic Repression Is a Crucial Target for Histone Deacetylase Inhibitors in Cutaneous T-Cell Lymphoma
Wenjing Fu, Shengguo Yi, Lei Qiu, et al.
Journal of Investigative Dermatology (2017) Vol. 137, Iss. 7, pp. 1523-1532
Open Access | Times Cited: 19
Wenjing Fu, Shengguo Yi, Lei Qiu, et al.
Journal of Investigative Dermatology (2017) Vol. 137, Iss. 7, pp. 1523-1532
Open Access | Times Cited: 19
Cutaneous T Cell Lymphoma
Erik Peterson, Jason Weed, Kristen Lo Sicco, et al.
Dermatologic Clinics (2019) Vol. 37, Iss. 4, pp. 455-469
Closed Access | Times Cited: 19
Erik Peterson, Jason Weed, Kristen Lo Sicco, et al.
Dermatologic Clinics (2019) Vol. 37, Iss. 4, pp. 455-469
Closed Access | Times Cited: 19
The “m6A writer” METTL3 and the “m6A reader” IGF2BP2 regulate cutaneous T‐cell lymphomas progression via CDKN2A
Xinchen Wang, Maogui Hu, Lu Yu, et al.
Hematological Oncology (2022) Vol. 40, Iss. 4, pp. 567-576
Open Access | Times Cited: 10
Xinchen Wang, Maogui Hu, Lu Yu, et al.
Hematological Oncology (2022) Vol. 40, Iss. 4, pp. 567-576
Open Access | Times Cited: 10
Interleukin-26 (IL-26) is a novel anti-microbial peptide produced by T cells in response to staphylococcal enterotoxin
Anders Woetmann, Morten Alhede, Sally Dabelsteen, et al.
Oncotarget (2018) Vol. 9, Iss. 28, pp. 19481-19489
Open Access | Times Cited: 16
Anders Woetmann, Morten Alhede, Sally Dabelsteen, et al.
Oncotarget (2018) Vol. 9, Iss. 28, pp. 19481-19489
Open Access | Times Cited: 16
Malignant T cells activate endothelial cells via IL-17 F
Britt Lauenborg, Ivan V. Litvinov, Youwen Zhou, et al.
Blood Cancer Journal (2017) Vol. 7, Iss. 7, pp. e586-e586
Open Access | Times Cited: 14
Britt Lauenborg, Ivan V. Litvinov, Youwen Zhou, et al.
Blood Cancer Journal (2017) Vol. 7, Iss. 7, pp. e586-e586
Open Access | Times Cited: 14
Genome profiling revealed the activation of IL2RG/JAK3/STAT5 in peripheral T‑cell lymphoma expressing the ITK‑SYK fusion gene
Lei‐Lei Zhang, Huaxiong Pan, Yixuan Wang, et al.
International Journal of Oncology (2019)
Open Access | Times Cited: 12
Lei‐Lei Zhang, Huaxiong Pan, Yixuan Wang, et al.
International Journal of Oncology (2019)
Open Access | Times Cited: 12
The Tumor Microenvironment as a Therapeutic Target in Cutaneous T Cell Lymphoma
Louis Boafo Kwantwi, Steven T. Rosen, Christiane Querfeld
Cancers (2024) Vol. 16, Iss. 19, pp. 3368-3368
Open Access | Times Cited: 1
Louis Boafo Kwantwi, Steven T. Rosen, Christiane Querfeld
Cancers (2024) Vol. 16, Iss. 19, pp. 3368-3368
Open Access | Times Cited: 1
Targeting TRAF3IP2, Compared to Rab27, is More Effective in Suppressing the Development and Metastasis of Breast Cancer
Eckhard Alt, Philipp M. Wörner, Andreas Pfnür, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Eckhard Alt, Philipp M. Wörner, Andreas Pfnür, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Angiogenesis in cutaneous T‑cell lymphoma ‑ proteomic approaches (Review)
Cristiana Tănase, Ionela Daniela Popescu, Ana‐Maria Enciu, et al.
Oncology Letters (2018)
Open Access | Times Cited: 6
Cristiana Tănase, Ionela Daniela Popescu, Ana‐Maria Enciu, et al.
Oncology Letters (2018)
Open Access | Times Cited: 6